WO2013181820A1

WO2013181820A1 - Clinical medication decision support system

Info

Publication number: WO2013181820A1
Application number: PCT/CN2012/076579
Authority: WO
Inventors: 樊代明; 李泽平; 熊利泽
Original assignee: 北京太元通软件科技有限公司
Priority date: 2012-06-07
Filing date: 2012-06-07
Publication date: 2013-12-12

Abstract

A clinical medication decision support system comprises a standard treatment medication module, used for providing diagnosis and treatment reference information and a medication reference scheme according to pathology and physiology information of a patient, so that a doctor can make a prescription; a medication safety reviewing module, used for reviewing the medication safety condition of the patient according to the prescription and generating a reviewing log; and a prescription monitoring and warning module, used for estimating the prescription and generating warning information according to the reviewing log. The system can automatically provide the medication scheme according to the pathology and physiology information of the patient, assist the doctor in making the prescription, review the safety of the prescription, estimate the prescription and conduct warning on the reviewing result, thereby remarkably improving the security, normalization and standardization of clinical medication; and furthermore, by setting an antibacterial agent management module, the effective management and monitoring on antibacterial agents are achieved, and the safety of the clinical medication is further improved.

Description

Clinical drug decision support system

Technical field

The invention belongs to the technical field of medical systems, and in particular relates to a clinical drug decision support system.

Background technique

In China, deepening the reform of the medical and health system is a systematic project involving a wide range of difficulties. On the one hand, China's medical resources are in short supply “difficult to see a doctor, expensive to see a doctor”. For example, there are 10 million people with epilepsy in China, and there are 400,000 new people each year, but in fact more than 40% have never been treated. About 35% of people accept informal treatment; on the other hand, the government and the people are paying for “excessive treatment and drug abuse”, for example, the use of antibiotics in major hospitals across the country, half of which are improperly applied every year. The economic loss of only abuse of antibiotics will reach more than one billion yuan.

In 2007, SFDA Drug Evaluation Center investigated the treatment of children with watery diarrhea in 26 hospitals in Beijing, Wuhan, Chongqing and Guangzhou. The rational use of drugs was only 5.4%; the appropriate treatment for pneumonia was only 12.3%. At the same time, due to the irregular use of drugs, the number of adverse reactions caused by patients has increased year by year. Dealing with such disputes has also cost the hospital a lot of time and energy.

The country still lacks scientific, fast, economic and effective means of supervision for the incredible waste caused by excessive medical treatment and the great harm and hidden dangers to national health. Therefore, the drug safety software is embedded in the HIS (Hospital Information Management System) in the form of controls. In the electronic prescription (doctoral) link, there may be damage to the patient in the presence of overdose, contraindications, incompatibility, interaction or incorrect input. A variety of prescriptions, establish a set of medication safety monitoring system, real-time warnings, tips, avoid the occurrence of phytotoxic accidents, improve the quality of medication in hospitals, prevent medical accidents and disputes, and ensure the safety of patient medication, has become a domestic hospital information monitoring system Consensus. However, at present, similar drug safety monitoring systems generally have a single function and are difficult to meet application requirements.

Summary of the invention

(1) Technical problems to be solved

The technical problem to be solved by the present invention is how to provide a clinical drug decision support system to improve the safety of clinical medication.

(2) Technical plan

To solve the above technical problem, the present invention provides a clinical medication decision support system, which includes:

The therapeutic medication specification module is configured to provide medical reference information and a medication reference scheme according to the patient's pathophysiological information for the doctor to prescribe;

a safe medication review module for reviewing the patient's medication safety based on the prescription and generating an examination log;

A prescription monitoring and early warning module for evaluating the prescription and generating warning information based on the review log.

Preferably, the therapeutic medication specification module comprises:

The disease diagnosis and treatment sub-module is configured to query a back-end database according to the patient's pathophysiological information, and then provide diagnosis and treatment reference information of the disease;

The therapeutic drug sub-module is configured to provide at least one medication reference plan according to the medical reference information for use by a doctor as a prescription.

Preferably, the safe medication review module further comprises:

A drug interaction review sub-module for administering two or more drugs at the same time or at intervals, reviewing possible drug interactions, and generating a corresponding review log;

A drug compatibility contraindication sub-module for reviewing possible contraindications between two or more drugs and generating a corresponding review log;

The drug use contraindication sub-module is used to review the contraindications for drug use and generate a corresponding review log;

The drug allergy reaction review sub-module is used to review the drugs in use according to the patient's allergens and generate a corresponding review log;

An adverse drug reaction review sub-module for reviewing drugs that may cause adverse reactions in patients and generating a corresponding review log;

The elderly drug review sub-module is used for safety review of elderly drugs and generates a corresponding review log;

The child medication review sub-module is used for safety review of medications for children of all ages and generates a corresponding review log;

The Pregnancy Women's Drug Examination sub-module is used to conduct a safety review of women's medication during pregnancy and generate a corresponding review log;

The lactation women's medication review sub-module is used for the safety review of lactating women's medication and generates a corresponding review log;

The liver function abnormal drug review sub-module is used for safety review of drugs for patients with abnormal liver function, and generates a corresponding review log;

The renal dysfunction medication review sub-module is used for safety review of patients with renal dysfunction and generates a corresponding review log;

A dosing sub-module for performing a safety review of the administered dose and generating a corresponding review log;

A drug delivery route review sub-module for performing a safety review of the route of administration and generating a corresponding review log;

The individualized drug administration review sub-module is used to automatically prompt the items and precautions for monitoring when the drug has a narrow therapeutic window in the prescription;

The re-use review sub-module is used for security review of drugs with repeated ingredients and generates a corresponding review log.

Preferably, the prescription monitoring and early warning module comprises:

a prescription evaluation sub-module for statistically evaluating the prescription and generating a corresponding evaluation form;

The prescription warning sub-module is configured to generate corresponding warning information according to the review log according to the corresponding problem existing in the prescription.

Preferably, the prescription evaluation sub-module further comprises:

a sample prescription evaluation unit for performing statistical analysis on the sample to be sampled and generating a prescription review worksheet;

An outpatient prescription review unit for manually reviewing the prescriptions in the current review form, and recording the review results, generating a review form reported to the Ministry of Health, and for viewing the historical review form;

a full sample prescription evaluation unit for evaluating the prescription of the whole sample and generating a corresponding evaluation form;

The prescription index evaluation unit is configured to perform statistical evaluation on specific prescription indicators of the prescription, and generate a corresponding evaluation form.

Preferably, the prescription warning sub-module comprises:

The drug adverse reaction early warning unit is configured to perform statistics on the adverse reaction problems of the same drug in a predetermined period of time in the clinical use according to the review log, and issue an early warning information of the adverse drug reaction when the number of occurrences of the adverse reaction problem reaches a corresponding threshold value ;

The incompatibility warning unit is configured to perform statistics on the incompatibility problems of the same group of drugs in a predetermined period of time in clinical use according to the examination log, and issue a contraindication warning information when the number of incompatibility problems reaches a corresponding threshold;

The interaction early warning unit is configured to perform statistics on the interaction problems of the same group of drugs in a predetermined period of time in clinical use according to the examination log, and issue an interaction early warning information when the number of occurrences of the interaction problem reaches a corresponding threshold;

The contraindication warning unit is configured to perform statistics on contraindications for consecutive occurrences of the same drug in a clinical use according to the review log, and issue a contraindication warning message when the number of occurrences of the contraindication syndrome reaches a corresponding threshold.

Preferably, the system further comprises: a rational medication supervision module;

The safe medication review module, in the process of reviewing the patient's medication safety according to the prescription, if the medication safety problem is found, the corresponding warning information will be recorded in the examination log;

The rational medication supervision module is configured to perform statistics and query on the warning information according to the examination log.

Preferably, the system further comprises:

The antibacterial drug management module is used for hierarchical authorization management of antibacterial drugs, as well as querying and statistical analysis of the actual use of antibacterial drugs.

Preferably, the antibacterial drug management module comprises:

A hierarchical management sub-module for setting the level of antibacterial drugs, the authority of doctors to use antibacterial drugs, and reviewing whether doctors use antibiotics in compliance with regulations and recording the results of the review;

The sub-quantitative statistics sub-module is used to use antibacterial drugs in violation of the department or doctor's statistics;

The usage sorting sub-module is used for sorting the antibacterial drugs according to the usage amount of different antibacterial drugs in a predetermined period of time;

The usage query sub-module is used to query the amount of the corresponding antibacterial drug, the cumulative DDD or the amount according to the department and the doctor;

The medication indicator sub-module is used to count the corresponding indicators of the patient's use of antibiotics during hospitalization;

The preventive medication indicator sub-module is used to count the corresponding indicators of the patient's use of antibacterial drugs during cleansing during hospitalization.

Preferably, the system further comprises: an online medical knowledge base module, configured to provide a query service for medical related information by retrieving a back-end database;

The online medical knowledge base module further includes:

The drug product sub-module is used to query the Chinese and Western drug product specifications approved by the SFDA;

The therapeutic drug sub-module is used for querying medical diagnosis reference information;

Standard treatment guidelines sub-module for industry-standard treatment guidelines for multiple diseases;

Clinical pathway sub-module for querying clinical pathways for multiple diseases;

Pregnancy medication safety classification sub-module for searching the classification safety information of pregnancy medication according to drug classification and drug name;

Antibacterial drug policy sub-module for querying policy documents related to the clinical application of antibacterial drugs;

The individualized drug sub-module is used for querying a drug list with a narrow therapeutic window, a test item for a related medicine with a narrow therapeutic window, a blood collection time, and a blood drug concentration range;

The normal value sub-module is tested for querying the normal value and significance of the clinical test;

A calculation formula sub-module for querying a medically relevant calculation formula;

The medical regulations sub-module is used to query the relevant contents of the national medical administration, drug administration, and health emergency.

(3) Beneficial effects

The clinical drug decision support system of the invention automatically provides a medication plan for the patient's pathophysiological information, assists the doctor to prescribe the prescription, conducts a safety review of the prescription, evaluates the prescription, and provides early warning of the examination result, which significantly improves the safety of the clinical medication. Sex, standardization and standardization, avoiding medication errors in hospitals, preventing medical risks, reducing disputes between doctors and patients, and improving medical quality. At the same time, through the establishment of the antibacterial drug management module, effective management and monitoring of antibacterial drugs is realized. , further improve the safety of clinical medication.

DRAWINGS

1 is a block diagram showing the structure of a clinical medication decision support system according to an embodiment of the present invention.

detailed description

The present invention will be further described in detail below with reference to the accompanying drawings and embodiments. It is understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.

1 is a block diagram showing the structure of a clinical medication decision support system according to an embodiment of the present invention. As shown in FIG. 1, the system includes a therapeutic medication specification module 100, a safety medication examination module 200, a prescription monitoring and early warning module 300, a rational medication supervision module 400, an antibacterial medication management module 500, and an online medical knowledge base module 600.

The therapeutic medication specification module 100 is configured to provide medical treatment reference information and a medication reference scheme according to the patient's pathophysiological information for the doctor to prescribe.

The safe medication review module 200 is configured to review the medication safety of the patient according to the prescription, and generate an examination log. During the review process, if the medication safety problem is found, the corresponding warning information will be recorded in the examination log; at the same time, the doctor will be prompted to re-apply the prescription and review the re-opened prescription again. The review here includes a review of the drug for a disease and a review of the drug for the complication of the disease.

The prescription monitoring and early warning module 300 is configured to evaluate the prescription and generate early warning information according to the examination log.

The reasonable medication supervision module 400 is configured to perform statistics and query on the warning information according to the examination log.

The antibacterial drug management module 500 is used for hierarchical authorization management of antibacterial drugs, and for querying and statistical analysis of actual use of antibacterial drugs.

The online medical knowledge base module 600 is configured to provide a query service for providing medical related information by searching a backstage database.

The therapeutic medication specification module 100 includes:

The disease diagnosis and treatment sub-module is used for querying the background database according to the patient's pathophysiological information, and then providing medical diagnosis and treatment reference information. When the patient's pathophysiological information is input to the disease diagnosis and treatment sub-module through the input device, the disease diagnosis and treatment sub-module carries the patient's pathophysiological information through the background database and the pathological and physiological information of the common common disease and high incidence, when the patient's pathophysiological information is in the background. In the database, firstly, the medical and surgical reference information of the disease corresponding to the pathophysiological information is displayed, including disease summary, diagnosis basis, differential diagnosis, clinical classification, drug treatment, complication treatment, condition monitoring and the like.

The therapeutic drug sub-module is configured to provide at least one medication reference plan according to the medical reference information for use by a doctor as a prescription. The medication reference protocol includes specific medication standards.

The safe medication review module 200 further includes:

A drug interaction review sub-module for reviewing two or more drugs at the same time or at intervals, reviewing possible drug interactions, and generating a corresponding review log.

A drug incompatibility review sub-module for reviewing possible contraindications between two or more drugs and generating a corresponding review log.

The drug use contraindication sub-module is used to review the contraindications for drug use and generate a corresponding review log.

The drug allergy reaction review sub-module is used to review the drugs in use according to the patient's allergens and generate a corresponding review log.

The Adverse Drug Reactions Review sub-module is used to review drugs that may cause adverse reactions in patients and generate a corresponding review log.

The elderly drug review sub-module is used for safety review of elderly drugs and generates a corresponding review log.

The Children's Drug Examination sub-module is used for safety review of medications for children of all ages and generates a corresponding review log.

The Pregnancy Women's Drug Examining Module is used to conduct a safety review of women's medication during pregnancy and to generate a corresponding review log.

The lactation women's medication review sub-module is used for the safety review of lactating women's medications and generates a corresponding review log.

The liver function abnormal drug review sub-module is used for safety review of drugs for patients with abnormal liver function, and generates a corresponding review log.

The renal dysfunction medication review sub-module is used for safety review of patients with renal dysfunction and generates a corresponding review log.

A dosing sub-module is administered to perform a safety review of the administered dose and generate a corresponding review log.

A route of administration review sub-module for performing a safety review of the route of administration and generating a corresponding review log.

The individualized drug administration review sub-module is used to automatically prompt the items and precautions that need to be monitored when the drug with a narrow therapeutic window appears in the prescription. The drug having a narrow therapeutic window includes at least: cyclosporine, digoxin, flecainide, lithium preparation, phenytoin, sirolimus, tacrolimus, theophylline, warfarin.

The prescription monitoring and early warning module 300 includes:

A prescription evaluation sub-module for statistically evaluating the prescription and generating a corresponding evaluation form.

The prescription evaluation sub-module further includes:

A sample prescription evaluation unit is configured to perform statistical analysis on the sample to be sampled and generate a prescription review worksheet.

The outpatient prescription review unit is used for manual review of the prescriptions in the current review form, and records the review results, generates a review form reported to the Ministry of Health, and is used to view the historical review form.

A full sample prescription evaluation unit for evaluating the prescription of the entire sample and generating a corresponding evaluation form.

The prescription warning sub-module includes:

The drug adverse reaction early warning unit is configured to perform statistics on the adverse reaction problems of the same drug in a predetermined period of time in the clinical use according to the review log, and issue an early warning information of the adverse drug reaction when the number of occurrences of the adverse reaction problem reaches a corresponding threshold value . The threshold value here should be set according to the actual situation, for example, set to 5, 10 or 15, etc., and is preferably set to 10 in this embodiment. The following threshold conditions are similar and will not be described here.

The incompatibility warning unit is used for counting the incompatibility problems of the same group of drugs in the clinical use for a predetermined time according to the examination log, and issuing the incompatibility warning information when the number of incompatibility problems reaches the corresponding threshold.

The reasonable medication supervision module 400 is configured to perform statistics and query on the warning information according to the examination log. Specifically, the reasonable medication supervision module 400 may perform statistics on the warning information according to the warning level in the whole hospital, and may perform statistics on the warning information according to the type of examination in the whole hospital, which may be described according to the department. The warning information is counted, and the warning information may be counted according to the type of examination in the department, and the warning information may be counted according to the doctor, or the warning information may be counted according to the type of examination for different doctors. The type of review here corresponds to 15 sub-modules of the safe medication review module 200, including 15 types of drug interactions, drug incompatibility contraindications, and drug use contraindications.

The antibacterial drug management module 500 includes:

The hierarchical management sub-module is used to set the level of antibacterial drugs, the authority of doctors to use antibacterial drugs, and to examine whether doctors use antibiotics in compliance with regulations and record the results of the review.

The sub-quantitative statistics sub-module is used to use antibacterial drugs in violation of the department or doctor's statistics.

The usage sorting sub-module is used to sort the antibacterial drugs according to the usage amount of different antibacterial drugs in a predetermined period of time.

Usage query sub-module, used to check the amount of antibiotics according to departments and doctors, cumulative DDD (defined daily Dose, limit daily dose) or amount.

The medication indicator sub-module is used to count the corresponding indicators of the patient's use of antibiotics during hospitalization.

The antibacterial drug management module 500, in reviewing whether the doctor's use of the antibacterial drug meets the requirements, the data source is the HIS (Hospital Information System) system, and the HIS system stores the prescription data of the whole hospital in real time, the antibacterial The medication management module 500 periodically extracts prescription data from the HIS system, and then reviews whether the use of the antimicrobial drug meets the requirements, and records the results of the review.

The online medical knowledge base module 600 further includes:

The drug product sub-module is used to query the Chinese and Western drug product manual approved by the SFDA (National Food and Drug Administration);

It should be noted that the therapeutic medicine sub-module in the online medical knowledge base module 600 and the disease diagnosis and treatment sub-module in the therapeutic medication specification module 100 have similar functions, and the data sources are similar. Therefore, the online medical knowledge base module 600 and the therapeutic medication specification module 100 employ the same back-end database to save implementation costs. Those skilled in the art will readily appreciate that the above two modules may also employ different back-end databases.

The clinical drug decision support system according to the embodiment of the invention automatically provides a medication plan for the patient's pathophysiological information, assists the doctor in prescribing a prescription, conducts a safety review of the prescription, and evaluates the prescription, and provides early warning of the examination result, which significantly improves the clinical The safety, speed and order of medications have circumvented the hospital's medication errors, prevented medical risks, reduced doctor-patient disputes, and improved medical quality.

The above is only the preferred embodiment of the present invention, and is not intended to limit the present invention. Any modifications, variations, equivalents, and improvements made within the spirit and scope of the present invention should be included in the present invention. Within the scope of protection of the invention.

Industrial applicability

The clinical drug decision support system of the invention automatically provides a medication plan for the patient's pathophysiological information, assists the doctor to prescribe the prescription, conducts a safety review of the prescription, evaluates the prescription, and provides early warning of the examination result, which significantly improves the safety of the clinical medication. Sex, quickness and ordering, avoiding medication errors in hospitals, preventing medical risks, reducing disputes between doctors and patients, improving medical quality, and industrial applicability; at the same time, by setting up the antibacterial drug management module, The effective management and monitoring of antibacterial drugs further improves the safety of clinical drugs.

Claims

Claims

A clinical medication decision support system, comprising:

The therapeutic medication specification module is configured to provide medical reference information and a medication reference scheme according to the patient's pathophysiological information for the doctor to prescribe;

a safe medication review module for reviewing the patient's medication safety based on the prescription and generating an examination log;

A prescription monitoring and early warning module for evaluating the prescription and generating warning information based on the review log.

2. The system of claim 1 wherein said therapeutic medication specification module comprises:

The disease diagnosis and treatment sub-module is configured to query a back-end database according to the patient's pathophysiological information, and then provide diagnosis and treatment reference information of the disease;

The therapeutic drug sub-module is configured to provide at least one medication reference plan according to the medical reference information for use by a doctor as a prescription.

3. The system of claim 1 wherein the safe medication review module further comprises:

A drug interaction review sub-module for administering two or more drugs at the same time or at intervals, reviewing possible drug interactions, and generating a corresponding review log;

A drug compatibility contraindication sub-module for reviewing possible contraindications between two or more drugs and generating a corresponding review log;

The drug use contraindication sub-module is used to review the contraindications for drug use and generate a corresponding review log;

The drug allergy reaction review sub-module is used to review the drugs in use according to the patient's allergens and generate a corresponding review log;

An adverse drug reaction review sub-module for reviewing drugs that may cause adverse reactions in patients and generating a corresponding review log;

The elderly drug review sub-module is used for safety review of elderly drugs and generates a corresponding review log;

The child medication review sub-module is used for safety review of medications for children of all ages and generates a corresponding review log;

The Pregnancy Women's Drug Examination sub-module is used to conduct a safety review of women's medication during pregnancy and generate a corresponding review log;

The lactation women's medication review sub-module is used for the safety review of lactating women's medication and generates a corresponding review log;

The liver function abnormal drug review sub-module is used for safety review of drugs for patients with abnormal liver function, and generates a corresponding review log;

The renal dysfunction medication review sub-module is used for safety review of patients with renal dysfunction and generates a corresponding review log;

A dosing sub-module for performing a safety review of the administered dose and generating a corresponding review log;

A drug delivery route review sub-module for performing a safety review of the route of administration and generating a corresponding review log;

The individualized drug administration review sub-module is used to automatically prompt the items and precautions for monitoring when the drug has a narrow therapeutic window in the prescription;

The re-use review sub-module is used for security review of drugs with repeated ingredients and generates a corresponding review log.

4. The system of claim 1 wherein said prescription monitoring and alerting module comprises:

a prescription evaluation sub-module for statistically evaluating the prescription and generating a corresponding evaluation form;

The prescription warning sub-module is configured to generate corresponding warning information according to the review log according to the corresponding problem existing in the prescription.

5. The system of claim 4, wherein the prescription evaluation sub-module further comprises:

a sample prescription evaluation unit for performing statistical analysis on the sample to be sampled and generating a prescription review worksheet;

An outpatient prescription review unit for manually reviewing the prescriptions in the current review form, and recording the review results, generating a review form reported to the Ministry of Health, and for viewing the historical review form;

a full sample prescription evaluation unit for evaluating the prescription of the whole sample and generating a corresponding evaluation form;

The prescription index evaluation unit is configured to perform statistical evaluation on specific prescription indicators of the prescription, and generate a corresponding evaluation form.

6. The system of claim 4 wherein said prescription alert sub-module comprises:

The drug adverse reaction early warning unit is configured to perform statistics on the adverse reaction problems of the same drug in a predetermined period of time in the clinical use according to the review log, and issue an early warning information of the adverse drug reaction when the number of occurrences of the adverse reaction problem reaches a corresponding threshold value ;

The incompatibility warning unit is configured to perform statistics on the incompatibility problems of the same group of drugs in a predetermined period of time in clinical use according to the examination log, and issue a contraindication warning information when the number of incompatibility problems reaches a corresponding threshold;

The interaction early warning unit is configured to perform statistics on the interaction problems of the same group of drugs in a predetermined period of time in clinical use according to the examination log, and issue an interaction early warning information when the number of occurrences of the interaction problem reaches a corresponding threshold;

The contraindication warning unit is configured to perform statistics on contraindications for consecutive occurrences of the same drug in a clinical use according to the review log, and issue a contraindication warning message when the number of occurrences of the contraindication syndrome reaches a corresponding threshold.

7. The system of claim 1 wherein said system further comprises: a rational medication monitoring module;

The safe medication review module, in the process of reviewing the patient's medication safety according to the prescription, if the medication safety problem is found, the corresponding warning information will be recorded in the examination log;

The rational medication supervision module is configured to perform statistics and query on the warning information according to the examination log.

8. The system of claim 1 wherein the system further comprises:

The antibacterial drug management module is used for hierarchical authorization management of antibacterial drugs, as well as querying and statistical analysis of the actual use of antibacterial drugs.

9. The system of claim 8 wherein said antimicrobial management module comprises:

A hierarchical management sub-module for setting the level of antibacterial drugs, the authority of doctors to use antibacterial drugs, and reviewing whether doctors use antibiotics in compliance with regulations and recording the results of the review;

The sub-quantitative statistics sub-module is used to use antibacterial drugs in violation of the department or doctor's statistics;

The usage sorting sub-module is used for sorting the antibacterial drugs according to the usage amount of different antibacterial drugs in a predetermined period of time;

The usage query sub-module is used to query the amount of the corresponding antibacterial drug, the cumulative DDD or the amount according to the department and the doctor;

The medication indicator sub-module is used to count the corresponding indicators of the patient's use of antibiotics during hospitalization;

The preventive medication indicator sub-module is used to count the corresponding indicators of the patient's use of antibacterial drugs during cleansing during hospitalization.

10. The system of claim 1, wherein the system further comprises: an online medical knowledge base module for providing a query service for providing medical related information by retrieving a back-end database;

The online medical knowledge base module further includes:

The drug product sub-module is used to query the Chinese and Western drug product specifications approved by the SFDA;

The therapeutic drug sub-module is used for querying medical diagnosis reference information;

Standard treatment guidelines sub-module for industry-standard treatment guidelines for multiple diseases;

Clinical pathway sub-module for querying clinical pathways for multiple diseases;

Pregnancy medication safety classification sub-module for searching the classification safety information of pregnancy medication according to drug classification and drug name;

Antibacterial drug policy sub-module for querying policy documents related to the clinical application of antibacterial drugs;

The individualized drug sub-module is used for querying a drug list with a narrow therapeutic window, a test item for a related medicine with a narrow therapeutic window, a blood collection time, and a blood drug concentration range;

The normal value sub-module is tested for querying the normal value and significance of the clinical test;

A calculation formula sub-module for querying a medically relevant calculation formula;

The medical regulations sub-module is used to query the relevant contents of the national medical administration, drug administration, and health emergency.